New Key Statistics Module, Z-Score and F-Score
NAS:FOLD Key Ratios
| Market Cap $ M | 3,044.69 |
| Enterprise Value $ M | 3,170.97 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 18.69 |
| Price/Sales | 7.48 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 399.00 |
| EPS (TTM) $ | -0.51 |
| Beneish M-Score | -2.58 |
| 10-y EBITDA Growth Rate % | 9.30 |
| 5-y EBITDA Growth Rate % | 26.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -31.72 |
| EV-to-EBITDA | -34.44 |
| PEG | -- |
| Shares Outstanding M | 296.18 |
| Net Margin (%) | -37.96 |
| Operating Margin % | -18.40 |
| Pre-tax Margin (%) | -37.59 |
| Quick Ratio | 2.52 |
| Current Ratio | 2.88 |
| ROA % (ttm) | -20.50 |
| ROE % (ttm) | -120.19 |
| ROIC % (ttm) | -22.26 |
| Dividend Yield % | -- |
| Altman Z-Score | -1.33 |
FOLD Number of Guru Trades
FOLD Volume of Guru Trades
Gurus Latest Trades with NAS:FOLD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:FOLD is held by these investors
Total 2
Amicus Therapeutics Inc Insider Transactions
No Available Data
News about NAS:FOLD
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers